Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Gain Therapeutics Announces Pricing Of $9.4M Public Offering Of 2,213,044 Shares At $2.005/Share And Accompanying Warrants; Concurrent Private Placement With Completion Of Public Offering Of 2,500,088 Shares At $2/Share

Author: Benzinga Newsdesk | November 21, 2023 09:57am

Posted In: GANX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist